Certificate Number,Certificate
50946/11-7-2023,
DE_NW_03_GMP_2023_0100,
DE_NW_03_GMP_2023_0101,
BE/GMP/2023/028,
FIMEA/2022/007473,
IT/43/H/2023,
DE_NW_05_GMP_2023_0049,
2023_HPF_FR_007,
2023_HPF_FR_008,
IT/154/H/2022,
NL/H 22/2039950,
IT/132/H/2023,
BE/GMP/2021/150,
DE_HE_01_GMP_2022_0031,
NL/H 21/2035815,
IT/18/H/2022,
2022_HPF_FR_063,
2022_HPF_FR_064,
016/2021/RO,
IWSF.405.92.2021.IP.1.1	 WTC/0129_02_01/233,
MT/035HM/2021,
134/2021/GMP,
401-11/2021-5,
480019-100289676,
480019-100291984,
480019-100813154,
480019-101316348,
480019-13759117,
BE/GMP/2021/124,
BE/GMP/2021/125,
ES/144HV/21,
IT-API/161/H/2021,
IWSF.405.102.2021.IP.2  WTC/0272_03_01/257,
IWSF.405.102.2021.IP.3  WTC/0272_04_01/258,
IWSF.405.102.2021.IP.5 WTC/0272_05_01/260,
IWSF.405.102.2021IP.4 WTC/0272_02_01/259,
IWSF405.102.2021.IP.1 WTC/0272_01_01/256,
IWSF405.102.2021.IP.6 WTC/0272_01_01/2261,
IWZJ.405.102.2021.IP.10 WTC/0272_05_01/265,
IWZJ.405.102.2021.IP.7 WTC/0272_03_01/262,
IWZJ.405.102.2021.IP.8 WTC/0272_04_01/263,
IWZJ.405.102.2021.IP.9 WTC/0272_02_01/264,
OGYÉI/43711-8/2021,
OGYÉI/43711-9/2021,
sukls170350/2021,
482297-102125188,
482297-14173866,
DE_BW_01_GMP_2021_0118,
DE_BW_01_GMP_2021_0119,
DE_BW_01_GMP_2021_0123,
DE_BW_01_GMP_2021_0124,
DE_BW_01_GMP_2021_0125,
DE_BW_01_GMP_2021_0126,
DE_BW_01_GMP_2021_0131,
DE_NW_01_GMP_2021_0022,
ES/190HVI/21,
IT-API/45/H/2022,
NBF/5/2022/V,
CG-HU/22V/2021.,
ES/149HV/21,
NBF/44/2021/V,
NL/H 21/2029178,
NL/H 21/2031529,
030/2021/RO,
sukls172422/2021,
107498/ 11-10--2022,
2021/HPF/FR/165,
2021/HPF/FR/166,
2021/HPF/FR/177,
2021/HPF/FR/178,
2021/HPF/FR/200,
2021/HPF/FR/214,
21MB031HFR01,
ES/145HVI/21,
IWSF.405.100.2021.IP.1 WTC/0054_01_01/254,
IWSF.405.90.2021.IP.1 WTC/0266_01_01/225,
IWSF.405.90.2021.IP.2 WTC/0266_02_01/226,
IWSF.405.90.2021.IP.3 WTC/0266_03_01/227,
IWSF.405.90.2021.IP.4  WTC/01266_04_01/228,
IWSF.405.90.2021.IP.5.1 WTC/0266_05_01/229,
OGYÉI/41548-7/2021,
2022_HPF_FR_036,
2022_HPF_FR_037,
21/299119,
21MPP046HFR01,
DK H 10000238,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.1  Large volume liquids 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.17  Other: Adjuvances for vaccines(en) 1.2.2  Batch certification 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
DK H 10000241,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.3  Other
DK IMP 10000285,2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.1  Site of physical importation
DK V 10000239,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.1  Large volume liquids 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
DK V 10000240,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.3  Other
IT-API/103/H/2021,
IWSF.405.98.2021.IP.1 WTC/0435_01_01/251,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.1.3  Batch certification 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.3  Chemical/Physical 1.6.4  Biological
IWSF.405.98.2021.IP.2 WTC/0435_01_02/252,
IWSF.405.99.2021.IP.1 WTC/0384_01_01/253,1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.2  Secondary packaging
MED01/2021/001,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.8  Other solid dosage forms: Gastro resistant tablets, modified release tablets and film coated tablets(en) 1.2.1.13  Tablets 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.8  Other solid dosage forms: Gastro resistant tablets, modified release tablets and film coated tablets(en) 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.2  Importation of intermediate which undergoes further processing"
MED02/2021/001,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.6  Liquids for internal use 1.2.1.11  Semi-solids 1.2.1.12  Suppositories 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.6  Liquids for internal use 1.5.1.11  Semi-solids 1.5.1.12  Suppositories 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.2  Importation of intermediate which undergoes further processing
MU(ES)/NCF/02/21,
OGYÉI/42549-7/2021,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: storage and sampling of finished products and semi-finished products(en) 2  IMPORTATION OF MEDICINAL PRODUCTS 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.4  Other: storage and sampling of finished products and semi-finished products(en)
OGYÉI/42549-9/2021,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: storage and sampling of finished products and semi-finished products(en) 2  IMPORTATION OF MEDICINAL PRODUCTS 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.4  Other: storage and sampling of finished products and semi-finished products(en)
SK-V/2309/2021/CGMP,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.1  Large volume liquids 1.1.2.3  Small volume liquids 1.1.3  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.5  Liquids for external use 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
UP/I-530-10/21-03/06; 381-13-08/338-23-12,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.7  Medicinal gases 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.7  Medicinal gases 1.6  Quality control testing 1.6.3  Chemical/Physical
UP/I-530-10/21-03/06; 381-13-08/338-23-13,
2022_HPF_FR_147,1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.2  Secondary packaging 2  IMPORTATION OF MEDICINAL PRODUCTS 2.3  Other importation activities 2.3.1  Site of physical importation
481324-100486933,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.2  Batch Certification (list of product types) 1.3.2.2  Immunological products 1.3.2.5  Biotechnology products 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.2  Immunological products 2.2.3.5  Biotechnology products 2.3  Other importation activities 2.3.4  Other: Wirkstoffe: Enoxaparin Natrium, Wirkstoffe: Enoxaparin Natrium(en)"
481324-14173673,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.2  Batch Certification (list of product types) 1.3.2.2  Immunological products 1.3.2.5  Biotechnology products 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.2  Immunological products 2.2.3.5  Biotechnology products 2.3  Other importation activities 2.3.4  Other: Wirkstoffe: Enoxaparin Natrium, Wirkstoffe: Enoxaparin Natrium(en)"
481355-13727951,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.1.3  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.3  Cell therapy products 1.3.1.6  Human or animal extracted products 1.3.1.7  Tissue engineered products 1.3.1.8  Other: Gewebeprodukte / Tissue engineering: Skelettmuskelzellen, Hautfibroblasten, Haarfolikelzellen / myoblasts, skin fibroblasts, hair follicle cells, Gewebeprodukte / Tissue engineering: Skelettmuskelzellen, Hautfibroblasten, Haarfolikelzellen / myoblasts, skin fibroblasts, hair follicle cells(en) 1.3.2  Batch Certification (list of product types) 1.3.2.3  Cell therapy products 1.3.2.6  Human or animal extracted products 1.3.2.7  Tissue engineered products 1.3.2.8  Other: Gewebeprodukte / Tissue engineering: Skelettmuskelzellen, Hautfibroblasten, Haarfolikelzellen / myoblasts, skin fibroblasts, hair follicle cells, Gewebeprodukte / Tissue engineering: Skelettmuskelzellen, Hautfibroblasten, Haarfolikelzellen / myoblasts, skin fibroblasts, hair follicle cells(en) 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.4  Biological"
74216/ 29-7-2021,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.2  Batch Certification (list of product types) 1.3.2.2  Immunological products 1.5  Packaging 1.5.2  Secondary packaging 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.1  Site of physical importation
DE_BW_01_GMP_2021_0185,"1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.2  Capsules, soft shell 1.5.1.13  Tablets 1.5.2  Secondary packaging"
DE_BY_05_GMP_2023_0019,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.2  Batch certification 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
DE_NW_06_GMP_2021_0014,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.1  Large volume liquids 1.1.1.4  Small volume liquids Special Requirements               : 1  B-lactam Antibiotics 7  Other: Hormons or substances with hormonal effect.(en) 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms Special Requirements               : 1  B-lactam Antibiotics 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.6  Liquids for internal use 1.5.1.8  Other solid dosage forms Special Requirements               : 1  B-lactam Antibiotics 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical
DE_SH_01_GMP_2022_0039,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.2  Semi-solids 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.5  Liquids for external use Special Requirements               : 7  Other: Hormones /substances with hormonal activity(en) 1.2.1.6  Liquids for internal use Special Requirements               : 7  Other: Hormones /substances with hormonal activity(en) 1.2.1.11  Semi-solids Special Requirements               : 7  Other: Hormones /substances with hormonal activity(en) 1.2.1.13  Tablets Special Requirements               : 7  Other: Hormones /substances with hormonal activity(en) 1.2.1.17  Other: - Granulate - Triturations(en) Special Requirements               : 7  Other: Hormones /substances with hormonal activity(en) 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.11  Semi-solids 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.6  Human or animal extracted products 2.3  Other importation activities 2.3.1  Site of physical importation
DE_SH_01_GMP_2022_0040,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.11  Semi-solids Special Requirements               : 7  Other: Hormones /substances with hormonal activity(en) 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.11  Semi-solids 1.5.2  Secondary packaging
OGYÉI/41969-7/2021,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: storage and sampling of finished products and semi-finished products(en) 2  IMPORTATION OF MEDICINAL PRODUCTS 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.4  Other: storage and sampling of finished products and semi-finished products(en)
32142/IMP00073/00001,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.5  Biotechnology products 1.3.2  Batch Certification (list of product types) 1.3.2.4  Gene therapy products 1.3.2.5  Biotechnology products 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical 2.1.4  Biological 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.4  Gene therapy products 2.2.3.5  Biotechnology products
74181/30-7-21,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.8  Other solid dosage forms: Powders for internal use(en) 1.2.1.13  Tablets 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.8  Other solid dosage forms: Powders for internal use(en) 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
BE/GMP/2021/133,
DE_RP_01_GMP_2021_0022,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.8  Other solid dosage forms 1.2.1.11  Semi-solids 1.2.1.13  Tablets 1.2.1.17  Other: Granules, pellets, powder(en) 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.11  Semi-solids 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical"
DE_TH_01H_GMP_2021_0016,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.2  Batch Certification (list of product types) 1.3.2.5  Biotechnology products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.2  Capsules, soft shell 1.5.1.3  Chewing gums 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.5  Biotechnology products 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.4  Other: 2.3.3 Biological Active Substance(en)"
NL/H 21/2029462A,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.11  Semi-solids 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.11  Semi-solids 1.5.2  Secondary packaging 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.2  Importation of intermediate which undergoes further processing
NL/H 21/2029462B,2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.2  Importation of intermediate which undergoes further processing
NL/H 21/2029462C,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.2  Semi-solids 1.1.2.3  Small volume liquids 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.11  Semi-solids 1.2.1.13  Tablets 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.11  Semi-solids 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.2  Importation of intermediate which undergoes further processing"
NL/H 21/2029462D,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.2  Semi-solids 1.1.2.3  Small volume liquids 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.11  Semi-solids 1.2.1.13  Tablets 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.2  Capsules, soft shell 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.11  Semi-solids 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.1  Site of physical importation"
NL/H 21/2029462E,
NL/V 21/0007,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.13  Tablets 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical
NL/V 21/0008,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.2  Batch certification 2  IMPORTATION OF MEDICINAL PRODUCTS 2.3  Other importation activities 2.3.1  Site of physical importation
OGYÉI/41646-7/2021,
OGYÉI/41646-8/2021,
74215/ 30-7-2021 δις/ bis,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 1.6  Quality control testing 1.6.3  Chemical/Physical
033/2021/RO,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.8  Other solid dosage forms: film coated tablets,  vaginal tablets(en) 1.2.1.11  Semi-solids 1.2.1.12  Suppositories 1.2.1.13  Tablets Special Requirements               : 7  Other: Corticosteroids(en) 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.8  Other solid dosage forms: film coated tablets,  vaginal tablets(en) 1.5.1.11  Semi-solids 1.5.1.12  Suppositories 1.5.1.13  Tablets Special Requirements               : 7  Other: corticosteroids(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
034/2021/RO,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.8  Other solid dosage forms: film-coated tablets, vaginal tablets(en) 1.2.1.13  Tablets 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.8  Other solid dosage forms: film-coated tablets, vaginal tablets(en) 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
2021/HPF/FR/156,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.5  Biotechnology products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell Special Requirements               : 7  Other: sulphonamides, cytotoxic and hormonal products(en) 1.5.1.2  Capsules, soft shell Special Requirements               : 7  Other: sulphonamides, cytotoxic and hormonal products(en) 1.5.1.3  Chewing gums Special Requirements               : 7  Other: sulphonamides, cytotoxic and hormonal products(en) 1.5.1.4  Impregnated matrices Special Requirements               : 7  Other: sulphonamides, cytotoxic and hormonal products(en) 1.5.1.5  Liquids for external use Special Requirements               : 7  Other: sulphonamides, cytotoxic and hormonal products(en) 1.5.1.6  Liquids for internal use Special Requirements               : 7  Other: sulphonamides, cytotoxic and hormonal products(en) 1.5.1.11  Semi-solids Special Requirements               : 7  Other: sulphonamides, cytotoxic and hormonal products(en) 1.5.1.12  Suppositories Special Requirements               : 7  Other: sulphonamides, cytotoxic and hormonal products(en) 1.5.1.13  Tablets Special Requirements               : 7  Other: sulphonamides, cytotoxic and hormonal products(en) 1.5.1.14  Transdermal patches Special Requirements               : 7  Other: sulphonamides, cytotoxic and hormonal products(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.2  Importation of intermediate which undergoes further processing"
2021/HPF/FR/156_ND,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.5  Biotechnology products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell Special Requirements               : 7  Other: sulphonamides, cytotoxic and hormonal products(en) 1.5.1.2  Capsules, soft shell Special Requirements               : 7  Other: sulphonamides, cytotoxic and hormonal products(en) 1.5.1.3  Chewing gums Special Requirements               : 7  Other: sulphonamides, cytotoxic and hormonal products(en) 1.5.1.4  Impregnated matrices Special Requirements               : 7  Other: sulphonamides, cytotoxic and hormonal products(en) 1.5.1.5  Liquids for external use Special Requirements               : 7  Other: sulphonamides, cytotoxic and hormonal products(en) 1.5.1.6  Liquids for internal use Special Requirements               : 7  Other: sulphonamides, cytotoxic and hormonal products(en) 1.5.1.11  Semi-solids Special Requirements               : 7  Other: sulphonamides, cytotoxic and hormonal products(en) 1.5.1.12  Suppositories Special Requirements               : 7  Other: sulphonamides, cytotoxic and hormonal products(en) 1.5.1.13  Tablets Special Requirements               : 7  Other: sulphonamides, cytotoxic and hormonal products(en) 1.5.1.14  Transdermal patches Special Requirements               : 7  Other: sulphonamides, cytotoxic and hormonal products(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.2  Importation of intermediate which undergoes further processing"
2021/HPF/FR/157,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell Special Requirements               : 7  Other: sulphonamides, cytotoxic and hormonal products(en) 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms: oral powder, cutaneaous patch(en) Special Requirements               : 7  Other: sulphonamides, cytotoxic and hormonal products(en) 1.2.1.11  Semi-solids 1.2.1.13  Tablets 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.2  Immunological products 1.3.1.5  Biotechnology products 1.3.1.6  Human or animal extracted products 1.3.2  Batch Certification (list of product types) 1.3.2.2  Immunological products 1.3.2.4  Gene therapy products 1.3.2.5  Biotechnology products 1.3.2.6  Human or animal extracted products 1.4  Other products or manufacturing activity 1.4.3  Other: labelling of small volume liquids vials(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell Special Requirements               : 7  Other: sulphonamides, cytotoxic and hormonal products(en) 1.5.1.2  Capsules, soft shell Special Requirements               : 7  Other: sulphonamides, cytotoxic and hormonal products(en) 1.5.1.3  Chewing gums Special Requirements               : 7  Other: sulphonamides, cytotoxic and hormonal products(en) 1.5.1.4  Impregnated matrices Special Requirements               : 7  Other: sulphonamides, cytotoxic and hormonal products(en) 1.5.1.5  Liquids for external use Special Requirements               : 7  Other: sulphonamides, cytotoxic and hormonal products(en) 1.5.1.6  Liquids for internal use Special Requirements               : 7  Other: sulphonamides, cytotoxic and hormonal products(en) 1.5.1.8  Other solid dosage forms: oral powder, cutaneous patch(en) Special Requirements               : 7  Other: sulphonamides, cytotoxic and hormonal products(en) 1.5.1.11  Semi-solids Special Requirements               : 7  Other: sulphonamides, cytotoxic and hormonal products(en) 1.5.1.12  Suppositories Special Requirements               : 7  Other: sulphonamides, cytotoxic and hormonal products(en) 1.5.1.13  Tablets Special Requirements               : 7  Other: sulphonamides, cytotoxic and hormonal products(en) 1.5.1.14  Transdermal patches Special Requirements               : 7  Other: sulphonamides, cytotoxic and hormonal products(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.2  Immunological products 2.2.3.5  Biotechnology products 2.2.3.6  Human or animal extracted products 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.2  Importation of intermediate which undergoes further processing"
2021/HPF/FR/157_ND,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell Special Requirements               : 7  Other: sulphonamides, cytotoxic and hormonal products(en) 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms: oral powder, cutaneaous patch(en) 1.2.1.11  Semi-solids 1.2.1.13  Tablets 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.2  Immunological products 1.3.1.5  Biotechnology products 1.3.1.6  Human or animal extracted products 1.3.2  Batch Certification (list of product types) 1.3.2.2  Immunological products 1.3.2.4  Gene therapy products 1.3.2.5  Biotechnology products 1.3.2.6  Human or animal extracted products 1.4  Other products or manufacturing activity 1.4.3  Other: labelling of small volume liquids vials(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell Special Requirements               : 7  Other: sulphonamides, cytotoxic and hormonal products(en) 1.5.1.2  Capsules, soft shell Special Requirements               : 7  Other: sulphonamides, cytotoxic and hormonal products(en) 1.5.1.3  Chewing gums Special Requirements               : 7  Other: sulphonamides, cytotoxic and hormonal products(en) 1.5.1.4  Impregnated matrices Special Requirements               : 7  Other: sulphonamides, cytotoxic and hormonal products(en) 1.5.1.5  Liquids for external use Special Requirements               : 7  Other: sulphonamides, cytotoxic and hormonal products(en) 1.5.1.6  Liquids for internal use Special Requirements               : 7  Other: sulphonamides, cytotoxic and hormonal products(en) 1.5.1.8  Other solid dosage forms: oral powder, cutaneous patch(en) Special Requirements               : 7  Other: sulphonamides, cytotoxic and hormonal products(en) 1.5.1.11  Semi-solids Special Requirements               : 7  Other: sulphonamides, cytotoxic and hormonal products(en) 1.5.1.12  Suppositories Special Requirements               : 7  Other: sulphonamides, cytotoxic and hormonal products(en) 1.5.1.13  Tablets Special Requirements               : 7  Other: sulphonamides, cytotoxic and hormonal products(en) 1.5.1.14  Transdermal patches Special Requirements               : 7  Other: sulphonamides, cytotoxic and hormonal products(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.2  Immunological products 2.2.3.5  Biotechnology products 2.2.3.6  Human or animal extracted products 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.2  Importation of intermediate which undergoes further processing"
AUR22-047ASR12579,
DE_SN_01_GMP_2021_0031,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids Special Requirements               : 5  Radiopharmaceuticals 1.1.3  Batch certification 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical
IWSF.405.81.2021.IP.1 WTC/0399_01_01/240,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.3  Chemical/Physical
IWSF.405.87.2021.IP.1  WTC/0449_01_01/217,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.2  Importation of intermediate which undergoes further processing"
IWSF.405.87.2021.IP.2  WTC/0449_01_01/218,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 1.5  Packaging 1.5.2  Secondary packaging
IWSF.405.87.2021.IP.3  WTC/0449_01_01/219,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.13  Tablets 1.5.2  Secondary packaging 2  IMPORTATION OF MEDICINAL PRODUCTS 2.3  Other importation activities 2.3.1  Site of physical importation
IWSF.405.87.2021.IP.4 WTC/0449_02_01/220,2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.2  Importation of intermediate which undergoes further processing
IWSF.405.87.2021.IP.5  WTC/0449_02_02/221,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.3  Other: storage(en)
IWSF.405.87.2021.IP.6  WTC/0449_03_01/222,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.3  Other: storage(en) 2  IMPORTATION OF MEDICINAL PRODUCTS 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.2  Importation of intermediate which undergoes further processing
IWSF.405.93.2021.IP.1 WTC/0090_01_01/241,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.11  Semi-solids 1.2.1.17  Other: Other(en) 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.1  Herbal products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.11  Semi-solids 1.5.1.17  Other non-sterile medicinal products: Other(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical
IWSF.405.93.2021.IP.1.1 WTC/0090_01_01/241,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.11  Semi-solids 1.2.1.17  Other: Other(en) 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.1  Herbal products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.11  Semi-solids 1.5.1.17  Other non-sterile medicinal products: Other(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical
IWSF.405.93.2021.IP.2 WTC/0090_02_01/242,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.2  Batch certification 1.4  Other products or manufacturing activity 1.4.3  Other: Storage and distribution(en) 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
IWSF.405.97.2021.IP.1 WTC/0167_02_02/249,
IWSF.405.97.2021.IP.2 WTC/0167_01_02/250,
LT/04H/2021,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms 1.2.2  Batch certification 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.1  Herbal products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.8  Other solid dosage forms: Kitos kietos dozavimo formos(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical
30776/IMP048,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.5  Liquids for external use 1.2.1.11  Semi-solids 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.5  Liquids for external use 1.5.1.11  Semi-solids 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical
30776/M00206,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.5  Liquids for external use 1.2.1.11  Semi-solids 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.5  Liquids for external use 1.5.1.11  Semi-solids 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical
403/2021/CGMP,1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.2  Secondary packaging
CG-HU/24V/2021.,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.2  Immunological products
DE_HE_01_GMP_2021_0075,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.3  Chemical/Physical 1.6.4  Biological
DE_NW_01_GMP_2023_0016,1  MANUFACTURING OPERATIONS 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.1  Blood products 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Manufacturing of biological starting Materials Human plasma for fractionation from whole blood and by apheresis(en) 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.3  Chemical/Physical 1.6.4  Biological
DE_NW_03_GMP_2022_0049,"1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.2  Capsules, soft shell 1.5.1.13  Tablets 1.5.2  Secondary packaging"
DE_NW_03_GMP_2022_0050,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.3  Other importation activities 2.3.1  Site of physical importation
DE_ST_01_GMP_2021_0031,1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical
DE_ST_01_GMP_2021_0032,1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical
DK API-H 10000236,
DK H 10000376,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.3  Other: Storage of intermediate medicinal products. Storage of pre-filled syringes (NaCl) for use in finished medicinal products(en) 1.5  Packaging 1.5.2  Secondary packaging 2  IMPORTATION OF MEDICINAL PRODUCTS 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.2  Importation of intermediate which undergoes further processing
DK IMP 10000377,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.3  Other: Storage of intermediate medicinal products(en)
IWSF.405.85.2021.IP.1 WTC/0261_01_01/234,"1  MANUFACTURING OPERATIONS 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.1  Blood products 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: osocze do frakcjonowania z krwi pełnej, osocze do frakcjonowania z plazmaferezy, osocze ludzkie immunizowane(en) 1.6  Quality control testing 1.6.3  Chemical/Physical 1.6.4  Biological"
IWSF.405.85.2021.IP.2 WTC/0261_02_01/235,1  MANUFACTURING OPERATIONS 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.1  Blood products 1.6  Quality control testing 1.6.3  Chemical/Physical
IWSF.405.85.2021.IP.3 WTC/0261_03_01/236,1  MANUFACTURING OPERATIONS 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.1  Blood products 1.6  Quality control testing 1.6.3  Chemical/Physical
IWSF.405.85.2021.IP.4 WTC/0261_04_01/237,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: human plasma for fractionation(en)
IWSF.405.85.2021.IP.5 WTC/0261_05_01/238,1  MANUFACTURING OPERATIONS 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.1  Blood products 1.6  Quality control testing 1.6.3  Chemical/Physical
IWSF.405.85.2021.IP.6 WTC/0261_06_01/239,1  MANUFACTURING OPERATIONS 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.1  Blood products 1.6  Quality control testing 1.6.3  Chemical/Physical
NBF/61/2021/V,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.3  Small volume liquids 1.1.3  Batch certification 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
5.9.1-2024-003104,
BE/GMP/2021/086,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.5  Liquids for external use 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.5  Liquids for external use 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
BG/GMP/2021/183,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.8  Other solid dosage forms: < Effervescent tablets; Powders for oral solution>(en) 1.2.1.13  Tablets 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.8  Other solid dosage forms: < Effervescent tablets; Powders for oral solution>(en) 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
BPFMV/067/002/2021,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.6  Liquids for internal use 1.2.1.16  Veterinary premixes Special Requirements               : 1  B-lactam Antibiotics 1.2.1.17  Other: Other(en) Special Requirements               : 1  B-lactam Antibiotics 7  Other: soluble powders(en) 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
DE_BW_01_GMP_2021_0159,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms 1.2.1.13  Tablets 1.2.2  Batch certification 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.1  Herbal products 1.4.1.2  Homoeopathic products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.2  Capsules, soft shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.1  Site of physical importation"
DE_BW_01_GMP_2021_0111,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 1.5  Packaging 1.5.2  Secondary packaging 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised
DE_BW_01_GMP_2021_0112,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 1.5  Packaging 1.5.2  Secondary packaging 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised
DK H 10000249,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates 1.1.1.4  Small volume liquids 1.1.3  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.2  Immunological products 1.3.2  Batch Certification (list of product types) 1.3.2.2  Immunological products 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
DK IMP 10000250,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates 1.1.1.4  Small volume liquids 1.1.3  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.2  Immunological products 1.3.1.5  Biotechnology products 1.3.2  Batch Certification (list of product types) 1.3.2.2  Immunological products 1.3.2.5  Biotechnology products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.6  Liquids for internal use 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.3  Biological medicinal products 2.2.3.2  Immunological products 2.2.3.6  Human or animal extracted products
OGYÉI/38694-8/2021,
NCF/2140/001/CAT,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.5  Solids and implants Special Requirements               : 1  B-lactam Antibiotics 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.1  Microbiological: sterility 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products
sukls107318/2021,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical
019/2021/RO,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.8  Other solid dosage forms: coated tablets(en) 1.2.1.11  Semi-solids 1.2.1.12  Suppositories 1.2.1.13  Tablets 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.8  Other solid dosage forms: coated tablets(en) 1.5.1.11  Semi-solids 1.5.1.12  Suppositories 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
128484/ 20-12-2021,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.1.3  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.3  Cell therapy products 1.3.1.6  Human or animal extracted products 1.3.1.7  Tissue engineered products 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
2021/HPF/FR/175,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical
2021/HPF/FR/176,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical
2022_HPF_FR_100,1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.2  Secondary packaging 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.1  Microbiological: sterility 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical 2.1.4  Biological 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.5  Biotechnology products 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.2  Importation of intermediate which undergoes further processing
2022_HPF_FR_101,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.2  Capsules, soft shell 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms: powder, granules(en) 1.2.1.11  Semi-solids 1.2.1.13  Tablets 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.2  Batch Certification (list of product types) 1.3.2.2  Immunological products 1.3.2.4  Gene therapy products 1.3.2.5  Biotechnology products 1.3.2.8  Other: probiotics(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.2  Capsules, soft shell 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.8  Other solid dosage forms: powder, granules(en) 1.5.1.11  Semi-solids 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.1  Microbiological: sterility 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical 2.1.4  Biological 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.3  Cell therapy products 2.2.3.5  Biotechnology products 2.2.3.6  Human or animal extracted products 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.2  Importation of intermediate which undergoes further processing"
21MPP039HFR01,
21MPP047HFR01,
BE/GMP/2021/074,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.3  Chemical/Physical 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical
BE/GMP/2021/075,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical
DE_TH_01H_GMP_2022_0004,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell Special Requirements               : 5  Radiopharmaceuticals 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell Special Requirements               : 5  Radiopharmaceuticals 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
IT-API/159/H/2021,
IWSF.405.91.2021.IP.1 WTC/0450_01_01/230,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.1.3  Batch certification 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical 1.6.4  Biological
IWSF.405.91.2021.IP.2 WTC/0450_01_01/231,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.1.3  Batch certification 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical 1.6.4  Biological
IWSF.405.91.2021.IP.3 WTC/0450_01_02/232,
IWSF.405.94.2021.IP.1.1 WTC/0348_01_02/244,
IWSF.405.95.2021.IP.1 WTC/0196_02_01/245,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.5  Liquids for external use 1.2.1.8  Other solid dosage forms: granules for oral suspension, powders for oral suspension(en) 1.2.1.13  Tablets 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.5  Liquids for external use 1.5.1.8  Other solid dosage forms: granules for oral suspension, powders for oral suspension(en) 1.5.1.13  Tablets 1.5.2  Secondary packaging"
IWSF.405.95.2021.IP.2  WTC/0196_02_01/246,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.8  Other solid dosage forms: powder for oral suspension(en) 1.2.1.13  Tablets 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.8  Other solid dosage forms: powder for oral suspension(en) 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
sukls136707/2021,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.1.3  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.3  Cell therapy products 1.3.2  Batch Certification (list of product types) 1.3.2.3  Cell therapy products 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical 1.6.4  Biological
480347-13759752,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.2  Semi-solids 1.1.2.3  Small volume liquids 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.2  Capsules, soft shell 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms 1.2.1.11  Semi-solids 1.2.1.12  Suppositories 1.2.1.13  Tablets 1.2.1.17  Other: Ovula / Ovules, Produkte mit hormonellen Wirkstoffen / products with hormone APIs(en) 1.2.2  Batch certification 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.1  Herbal products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.2  Capsules, soft shell 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.8  Other solid dosage forms 1.5.1.11  Semi-solids 1.5.1.12  Suppositories 1.5.1.13  Tablets 1.5.1.17  Other non-sterile medicinal products: Ovula / Ovules, Produkte mit hormonellen Wirkstoffen / products with hormone APIs(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
482968-13759661,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.1  Herbal products 1.4.1.2  Homoeopathic products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility
73537/ 29-7-2021,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
DE_BB_01_GMP_2021_0027,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.1  Herbal products 1.4.1.3  Other: batch release(en) Special Requirements               : 7  Other: Narcotics(en) 1.5  Packaging 1.5.2  Secondary packaging
DE_BB_01_GMP_2021_0028,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 1.5  Packaging 1.5.2  Secondary packaging
DE_BW_01_GMP_2021_0158,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.11  Semi-solids 1.2.2  Batch certification 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.1  Herbal products 1.4.1.2  Homoeopathic products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.11  Semi-solids 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical 1.6.4  Biological
DE_BW_01_GMP_2022_0017,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.2  Batch certification 1.4  Other products or manufacturing activity 1.4.3  Other: Filling, packaging and labelling of herbal medicinal teas, as well as tea bags.(en) 1.6  Quality control testing 1.6.3  Chemical/Physical"
DE_BW_01_GMP_2022_0018,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.2  Batch certification
DE_BY_04_GMP_2021_0078,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.8  Other solid dosage forms 1.2.1.13  Tablets 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.1  Herbal products 1.4.1.2  Homoeopathic products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.2  Capsules, soft shell 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical"
DE_NI_01_GMP_2021_0018,
DE_NW_03_GMP_2022_0028,"1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.2  Capsules, soft shell 1.5.1.8  Other solid dosage forms 1.5.1.13  Tablets"
DE_ST_01_GMP_2021_0046,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.2  Capsules, soft shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical"
ES/141/21,
IWSF.405.86.2021.IP.1 WTC/0374_01_01/216,
IWSF.405.96.2021.IP.1 WTC/0026_01_02/247,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.1  Site of physical importation
IWSF.405.96.2021.IP.2 WTC/0026_01_02/248,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.3  Chemical/Physical 1.6.4  Biological
NL/H 21/2029456,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.2  Batch certification 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products
NL/H 21/2029456V1A,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.2  Batch certification 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.5  Biotechnology products
NL/H 21/2029456V1B,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.2  Batch certification 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.5  Biotechnology products
OGYÉI/34541-9/2021,1  MANUFACTURING OPERATIONS 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.1  Blood products Special Requirements               : 7  Other: fresh frozen plasma by plasmapheresis(en)
OGYÉI/36941-7/2021,"1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Storage of medicinal products, raw materials and packaging materials(en) 1.5  Packaging 1.5.2  Secondary packaging"
sukls230757/2020,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.7  Medicinal gases 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.7  Medicinal gases 1.6  Quality control testing 1.6.3  Chemical/Physical
sukls230776/2020,
480777-100474384,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.4  Gene therapy products 1.3.1.5  Biotechnology products 1.3.2  Batch Certification (list of product types) 1.3.2.4  Gene therapy products 1.3.2.5  Biotechnology products 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.1  Microbiological: sterility 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical 2.1.4  Biological 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.3  Biological medicinal products 2.2.3.4  Gene therapy products 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.4  Other: Einfuhr von Zellbanken / Importation of cell banks(en)
480777-101542410,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.4  Gene therapy products 1.3.1.5  Biotechnology products 1.3.2  Batch Certification (list of product types) 1.3.2.4  Gene therapy products 1.3.2.5  Biotechnology products 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.1  Microbiological: sterility 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical 2.1.4  Biological 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.3  Biological medicinal products 2.2.3.4  Gene therapy products 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.4  Other: Einfuhr von Zellbanken/ Importation of cell banks, Einfuhr von Zellbanken/ Importation of cell banks(en)"
480777-102267798,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.4  Gene therapy products 1.3.1.5  Biotechnology products 1.3.2  Batch Certification (list of product types) 1.3.2.4  Gene therapy products 1.3.2.5  Biotechnology products 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Herstellung von pDNA und gamma retroviralen Vektoren als Startmaterial für die Gentherapieproduktion/manufacture of pDNA and gamma retroviral vectors (gRVs) as starting material in line with EU GMP Part IV, Herstellung von pDNA und gamma retroviralen Vektoren als Startmaterial für die Gentherapieproduktion/manufacture of pDNA and gamma retroviral vectors (gRVs) as starting material in line with EU GMP Part IV(en) 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.1  Microbiological: sterility 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical 2.1.4  Biological 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.3  Biological medicinal products 2.2.3.4  Gene therapy products 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.4  Other: Einfuhr von Zellbanken/ Importation of cell banks, Einfuhr von Zellbanken/ Importation of cell banks(en)"
480777-13757597,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.4  Gene therapy products 1.3.1.5  Biotechnology products 1.3.2  Batch Certification (list of product types) 1.3.2.4  Gene therapy products 1.3.2.5  Biotechnology products 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.1  Microbiological: sterility 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical 2.1.4  Biological 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.3  Biological medicinal products 2.2.3.4  Gene therapy products 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.4  Other: Einfuhr von Zellbanken/ Importation of cell banks(en)
63446/30-07-2021,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.8  Other solid dosage forms: water-soluble powder(en) 1.2.1.16  Veterinary premixes 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.8  Other solid dosage forms: water-soluble powder(en) 1.5.1.16  Veterinary premixes 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical
BE/GMP/2021/076,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates 1.1.1.4  Small volume liquids 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.3  Small volume liquids 1.1.3  Batch certification
BE/GMP/2021/077,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates 1.1.1.4  Small volume liquids 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.3  Small volume liquids 1.1.3  Batch certification
